Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex.

Wang HY, Zhang B, Zhou JN, Wang DX, Xu YC, Zeng Q, Jia YL, Xi JF, Nan X, He LJ, Yue W, Pei XT.

Cell Death Dis. 2019 Jun 11;10(6):453. doi: 10.1038/s41419-019-1676-0.

2.

TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.

Liu ZM, Tseng HY, Cheng YL, Yeh BW, Wu WJ, Huang HS.

Toxicol Appl Pharmacol. 2015 May 15;285(1):41-50. doi: 10.1016/j.taap.2015.03.007. Epub 2015 Mar 16.

PMID:
25791921
3.

Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.

Liu ZM, Tseng JT, Hong DY, Huang HS.

Biochem J. 2011 Sep 1;438(2):349-58. doi: 10.1042/BJ20101653.

PMID:
21649584
4.

Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.

Zhang X, Yang XR, Sun C, Hu B, Sun YF, Huang XW, Wang Z, He YF, Zeng HY, Qiu SJ, Cao Y, Fan J, Zhou J.

Cancer Lett. 2015 Sep 28;366(1):112-22. doi: 10.1016/j.canlet.2015.06.014. Epub 2015 Jun 25.

PMID:
26118777
5.

SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.

Huang A, Yue D, Liao D, Cheng L, Ma J, Wei Y, Tong A, Cheng P.

Oncol Rep. 2016 Dec;36(6):3283-3290. doi: 10.3892/or.2016.5161. Epub 2016 Oct 11.

PMID:
27748945
6.

Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.

Wang GZ, Zhang W, Fang ZT, Zhang W, Yang MJ, Yang GW, Li S, Zhu L, Wang LL, Zhang WS, Liu R, Qian S, Wang JH, Qu XD.

J Cancer Res Clin Oncol. 2014 Jul;140(7):1125-36. doi: 10.1007/s00432-014-1659-6. Epub 2014 Apr 23.

PMID:
24756364
7.

Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.

Cui L, Gao B, Cao Z, Chen X, Zhang S, Zhang W.

Mol Med Rep. 2016 Mar;13(3):2032-8. doi: 10.3892/mmr.2016.4757. Epub 2016 Jan 12.

8.

Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation.

Bell JB, Eckerdt F, Dhruv HD, Finlay D, Peng S, Kim S, Kroczynska B, Beauchamp EM, Alley K, Clymer J, Goldman S, Cheng SY, James CD, Nakano I, Horbinski C, Mazar AP, Vuori K, Kumthekar P, Raizer J, Berens ME, Platanias LC.

Mol Cancer Res. 2018 Jan;16(1):32-46. doi: 10.1158/1541-7786.MCR-17-0397. Epub 2017 Oct 17.

9.

Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14-3-3η/NF-κB feedback loop.

Qiu Y, Dai Y, Zhang C, Yang Y, Jin M, Shan W, Shen J, Lu M, Tang Z, Ju L, Wang Y, Jiao R, Xia Y, Huang G, Yang L, Li Y, Zhang J, Wong VKW, Jiang Z.

J Exp Clin Cancer Res. 2018 Dec 20;37(1):321. doi: 10.1186/s13046-018-1005-y.

10.

Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.

Zhao XS, Song PL, Sun B, Jiang HC, Liu TF.

Hepatobiliary Pancreat Dis Int. 2009 Oct;8(5):510-7.

11.

Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.

Song J, Zhao Z, Fan X, Chen M, Cheng X, Zhang D, Wu F, Ying X, Ji J.

Oncotarget. 2016 Oct 25;7(43):70504-70515. doi: 10.18632/oncotarget.12041.

12.

Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.

Alex AA, Ganesan S, Palani HK, Balasundaram N, David S, Lakshmi KM, Kulkarni UP, Nisham PN, Korula A, Devasia AJ, Janet NB, Abraham A, Srivastava A, George B, Padua RA, Chomienne C, Balasubramanian P, Mathews V.

Front Immunol. 2018 Jun 14;9:1357. doi: 10.3389/fimmu.2018.01357. eCollection 2018.

13.

Therapeutic Potential of Arsenic Trioxide (ATO) in Treatment of Hepatocellular Carcinoma: Role of Oxidative Stress in ATO-Induced Apoptosis.

Dugo EB, Yedjou CG, Stevens JJ, Tchounwou PB.

Ann Clin Pathol. 2017;5(1). pii: 1101. Epub 2017 Jan 4.

14.

Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells.

Yin Q, Sides M, Parsons CH, Flemington EK, Lasky JA.

Virol J. 2017 Jun 21;14(1):121. doi: 10.1186/s12985-017-0784-7.

15.

Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.

Ling S, Xie H, Yang F, Shan Q, Dai H, Zhuo J, Wei X, Song P, Zhou L, Xu X, Zheng S.

J Hematol Oncol. 2017 Feb 28;10(1):59. doi: 10.1186/s13045-017-0424-0.

16.

Calcium homeostasis and endoplasmic reticulum stress are involved in Salvianolic acid B-offered protection against cardiac toxicity of arsenic trioxide.

Zhang JY, Zhang B, Wang M, Wang W, Liao P, Sun GB, Sun XB.

Oncotarget. 2017 Oct 26;8(57):97384-97393. doi: 10.18632/oncotarget.22127. eCollection 2017 Nov 14.

17.

Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.

Ghavamzadeh A, Jalili M, Rostami S, Yaghmaie M, Aliabadi LS, Mousavi SA, Vaezi M, Fumani HK, Jahani M, Alimoghaddam K.

Leuk Res. 2018 Mar;66:85-88. doi: 10.1016/j.leukres.2018.01.019. Epub 2018 Feb 3. Erratum in: Leuk Res. 2018 Apr;67:116.

PMID:
29407588
18.

Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.

Jung YS, Cheong HJ, Kim SJ, Kim KH, Lee N, Park HS, Won JH.

Leuk Res. 2014 Aug;38(8):977-82. doi: 10.1016/j.leukres.2014.05.019. Epub 2014 Jun 4.

PMID:
24953245
19.

Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.

Zhai B, Jiang X, He C, Zhao D, Ma L, Xu L, Jiang H, Sun X.

Tumour Biol. 2015 Apr;36(4):2323-34. doi: 10.1007/s13277-014-2839-3. Epub 2014 Nov 22.

PMID:
25416439
20.

Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.

Li Y, Jiang F, Liu Q, Shen J, Wang X, Li Z, Zhang J, Lu X.

Toxicol Sci. 2015 Jan;143(1):156-64. doi: 10.1093/toxsci/kfu218. Epub 2014 Oct 10.

PMID:
25304214

Supplemental Content

Support Center